Pharma The general manager of Wörwag Pharma Czech Republic & Slovakia reviews to what degree the Czech and Slovak market are homogeneous and which strategies can be successfully transferred from one market to the other. She furthermore highlights the unique characteristics of Wörwag Pharma as an employer which results in highly…
Pharma The executive director of the French Chamber of Commerce and Industry (FCCI) in Singapore, Carine Lespayandel pinpoints the key facets of the Singaporean economy that have captivated the continued interests of French companies, while highlighting the chamber’s fundamental role in facilitating investment growth between the two countries moving forward. What…
Pharma Martin Naville, CEO of the Swiss-American Chamber of Commerce, discusses Swiss exports to the US, global competitiveness and innovation rankings, and why the Swiss-US relationship will only continue to grow stronger in the coming years. In 2015, the US was the most important destination for Swiss direct investment abroad, amounting…
Pharma Thilo Stadler speaks passionately about Grünenthal’s collaborative partnerships, company goals, and workforce engagement; revealing himself to be someone who truly believes in Grünenthal’s business. You currently hold the position of Regional General Manager South Europe and the Nordics and Managing Director of the Italian subsidiary. What were the main objectives…
Pharma The country manager of LEO Pharma Czech Republic and Slovakia explains how the recent acquisition of Astella’s dermatology portfolio will triple the revenue of the affiliate and how LEO always puts patients first Could you please introduce yourself and the cornerstones of your longstanding career in the pharmaceutical industry? The…
Pharma Since gaining independence in 1965, Singapore has invested heavily in moving beyond being a mere supplier of low cost labor like many of its Asian neighbors and pivoting into a more knowledge-based and innovation-intensive economy. Chemicals, engineering, and electronics have always served as key manufacturing segments, but only starting from…
Healthcare In part two of a two-part interview (read part one here), Mikel Arriola of the IMSS discusses the strategic roadmap IMSS will follow under his tenure with regards to innovation access and chronic disease prevention, as well as his approach to the upcoming implementation of exchanges of services among the…
Healthcare In part one of a two-part interview (read part two here), Mikel Arriola, the recently appointed general director of IMSS (Mexican Social Security Institute), which provides health-related services to more than 70 million beneficiaries, reveals his fundamental priorities to both secure IMSS’ financial sustainability and improve the quality of services…
Pharma Digitalization, a hot topic throughout the healthcare and life sciences industry, is having a major effect in Italy through more personalized home care for patients, allowing the government to cut costs, and enabling greater public access to innovative medical technologies. Telemedicine, a key differentiator in tender processes, is not yet used…
Pharma Merck Czech Republic’s MD reveals his plan to double Merck operations within the next five years and talks about the impact of the recent acquisition of Sigma Aldrich on the Czech Republic. You’ve assumed position as Managing Director Merck Czech Republic just over one year ago; what was the strategy…
Pharma The president of the Czech Academy of Sciences highlights the responsibility of leading scientists to consider the real life application of their academic results in addition to promoting the Czech sciences in world leading publications. Could you please briefly elaborate the history and background of the Czech Academy of Sciences?…
See our Cookie Privacy Policy Here